News, Resources, & Updates

Books
Schools
FAQs
All
  • All
  • Articles
  • Calendar
  • Compliance
  • Newsletter
  • Position Statements
  • Press Release
  • Regulatory
  • Uncategorized
Presidents message image

Board Retreat Topics 2023

By Mark Land, M.S., RAC, AAHP President   The AAHP Board Retreat is designed to give the board the opportunity to reflect on objectives and accomplishments...
Integragive Medicine Award Mike Wolf

AAHP Industry Reception with Walgreens’ Michael Wolf Accepting the Integrative Medicine Retailer Award

By Alissa Gould, AAHP Volunteer Communications Chair  The annual AAHP Industry Reception is back for its fifth year! Mark your calendars for this small-scale networking...
AAHP Amazon

Are You Ready to Launch a Product on Amazon?

By Ray Petrick, Vice President of Sales, Boiron USA  Amazon customers buy roughly 7,400 products per minute from U.S. sellers. It is a monster platform...
map

A High-Level Comparison of Homeopathic Product Regulation in the US, EU, and Canada

Two members of the AAHP Board, Mark Land and Eric Foxman, attended a June meeting with members of similar organizations from the European Union (EU),...
History of homeopathy SG

Snapshots from There and Then: History of Homeopathy

In honor of AAHP's 100th anniversary year, we're looking back at the history of homeopathy to learn how the medical modality spread worldwide. Readers will...
Retailer Award

AAHP Integrative Medicine Retailer Award: History and Philosophy

By Mark Land, M.S., RAC, AAHP President  For several years now, food, drug, and mass retailers have recognized the consumer shift toward integrative health. To...
HRI1

5th International Homeopathic Research Conference

By Mark Land, M.S., RAC, AAHP President  The Homeopathic Research Institute (HRI) held its 5th international research conference on homeopathy in London, June 15-18, 2023. The conference theme...
FDA Posts Backgrounds2

FDA Cracks Down on Testing for Glycerin Contaminants — Again

By Al Lorman, AAHP Counsel  The Food and Drug Administration (FDA) has begun another campaign to protect consumers from products that contain glycerin potentially contaminated...
Untitled design-18

FDA’s Center for Drug Evaluation and Research’s (CDER) Office of Compliance

By Mark Land, M.S., RAC, AAHP President The Office of Compliance (OC) shields patients from poor quality, unsafe, and ineffective drugs through compliance strategies and...